Asian Cardio Diabetes Forum 2019
Meeting report with video and slides of the Asian Cardio Diabetes Forum held on March 30-31 Hanoi, Vietnam on the novel therapeutic approaches in Diabetes & CVD - Videos of presentations will follow
Episodes 1-9 of 9
- Asian Cardio Diabetes Forum 2019ACDF Brief comments: What has changed significantly in evaluating and considering CV risk in managing patients with diabetes?1
Prof John E Deanfield
- Asian Cardio Diabetes Forum 2019ACDF Brief comments: The evolving role of SGLT2 inhibitors
Prof. Mark Cooper, MD
- Asian Cardio Diabetes Forum 2019ACDF Brief comments: Key challenges in reinforcing CV risk management among diabetic patients
Prof John E Deanfield
- Asian Cardio Diabetes Forum 2019ACDF Brief comments: The evolving role of SGLT2 inhibitors in heart failure?
- Asian Cardio Diabetes Forum 2019Lecture: SGLT2 inhibition in CVD & Diabetes: How can we explain the benefits?
Prof. Nikolaus Marx, MD
- Asian Cardio Diabetes Forum 2019Lecture: Heart Failure: The next frontier for SGLT2 inhibitors?
Prof. Nikolaus Marx, MD
- Asian Cardio Diabetes Forum 2019Lecture: Targeting HbA1c in diabetes management: What are the key lessons from glucose lowering trials?
Prof. Nikolaus Marx, MD
- Asian Cardio Diabetes Forum 2019Lecture: The Kidney: Opportunities for protection and prevention
- Asian Cardio Diabetes Forum 2019Lecture: Cardiovascular outcomes that will change diabetes practice: What are the key findings from recent trials
Prof. Mark Cooper, MD